Ingo Baumann, Thescon Managing Director and Lead Consultant, is co-author of a new publication on machine learning best practices in the GxP environment
Until now, the introduction of new AI-based methods in the pharmaceutical industry was significantly limited. Today, however, regulatory authorities have launched various initiatives to integrate artificial intelligence (AI) and machine learning (ML) into existing regulations for computerized systems. This development marks a significant advancement for the industry.
In a comprehensive article titled “Good Machine Learning Practices in GxP regulated areas,” Dr. Joerg Stueben, Martin
Heitmann, and Ingo Baumann provide an overview of these initiatives and explore the opportunities they present for the industry. The article offers valuable insights and practical guidelines for companies looking to integrate AI and ML technologies into their processes to improve efficiency and compliance.
Read the full article on ecv.de and learn how the latest regulatory initiatives can revolutionize the pharmaceutical industry.
About Ingo Baumann and Thescon
Ingo Baumann is managing director and consultant in the field of computerized systems and CSV (Computer System Validation). With extensive experience and deep expertise, he helps companies implement innovative technologies safely and efficiently.Thescon offers specialized consulting services and tailored solutions to meet the high demands of GxP-regulated areas. Our goal is to help our clients stay competitive by leveraging cutting-edge technologies and best practices.